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1. introduction 
Peroxisomes isolated from rat liver have been 
shown to j&oxidize fatty acids [ 1,2]. The hypolipi- 
daemic drug clofibrate (a-p-chloro-phenoxy- 
isobutyrate) induces proliferation of liver 
peroxisomes [3] andmitochondria 141, and stimulates 
peroxisomal oxidation of paImitate [5]. The 
metabolic role of peroxisomal fatty acid oxidation 
is not clear, ~thou~ it has been claimed that 
peroxisomes may be responsible for a major portion 
of the oxidation of palmitate normally attributed to 
mitochondria 121. 
A marked increase in the ability to oxidise fatty 
acids, in particular very long chain fatty acids, e.g., 
erucic acid, has been shown in hepatocytes i olated 
from rats fed clofibrate [6]. It is also clear that 
mitochondrial fatty acid oxidation is stimulated by 
clofibrate feeding. This effect is primariiy expressed 
with fatty acids shorter than palmitate, and there is 
only a rn~~~ st~~ato~ effect on oxidation of 
erucic acid 161. These findings, suggest that extra- 
mitochondri~ sites for oxidation of erucic acid are 
present in the rat liver. 
We have investigated the ability of isolated peroxi- 
somes to oxidize fatty acids of various chain lengths, 
and attempted to identify some oxidation products 
from peroxisomal oxidation of [ 14.r4C]erucoyl-CoA. 
A recent finding that NADP stimulates chain- 
shortening of [ 14-r4C!]erucic acid by mitochondrial 
preparations ]7], led us to examine the effect of NAD 
and NADP on peroxisomat oxidation of 
~14-14CJerucoyl~oA. 
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2. Materials and methods 
Brassidic acid (trar~s-~~,~ (g,), elaidic acid (trans- 
C1aZ1 &,, gadeoleic acid (c~s-~~:~ (11I) and erucic 
acid (c~s-~~,~ (g$ were purchased from Nu-Chek 
Preps., Elysian, MN. All other fatty acids were 
purchased from E. Merck, Darmstadt. Coenzyme A 
(grade 1 -L), Hepes (4-(2-hydroxyethyl)-1 -piperazine- 
ethanesulphonic a id) and EGTA were purchased 
from Sigma Chemical Co., St Louis, MO. [ 14-“4C]Erucic 
acid was purchased from CEA, Gif-sur-Yvette. Ah 
other reagents were of analytical grade, or highest 
purity available. 
Liver peroxisomes were prepared from male albino 
Wistar ats (200-250 g), which had been fed a 
standard pelleted iet containing 0.3% (w/w) 
clofibrate for 2-3 weeks. Livers were homogenised in
a medium containing 300 mM mannitol, 10 mM 
Hepes, 1 mM EGTA and 0.1% (v/v) ethanol (pH 7.2). 
From this a fraction similar to the L-fraction in [S] 
was prepared. About 1 ml (80 mg protein) of this 
fraction was layered on the top of a 42-5 1% (w/w) 
sucrose gradient (gradient vol. 30 ml). This was cen- 
trifuged at 54 300 X gav for 30 min in a SorvaIl 
OTD-65 ultracentrifuge, using a TV-850 vertical 
rotor. The pooled peroxisomal fractions were diluted 
with 3 vol. 5 mM Hepes (pH 7.4). The peroxisomes 
were subsequently sedimented at 32 000 X gav for 
15 min by using the SA-600 centrifuge head. The 
resulting pellet was resuspended in a minimal volume 
of homogenisation medium, giving a final 20-30 mg 
protein/ml, These peroxisomal preparations con- 
tained 24% of the uricase (EC 1.73.3) activity present 
in the starting homogenate. The cytochrome c
oxidase (EC 1.9.3 .l) activity (assayed in the presence 
of 0.02% (v/v) of Triton X-100) was only 0.2% of 
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that present in the starting homogenate. Contamina- 
tion from endoplasmic reticulum was similarly about 
1% (measured as rotenone-insensitive NADPH 
cytochrome c reductase (EC l&2.3), and about 6% 
with respect o lysosomes (measured as /I-iv-acetyl-D- 
glucoseaminidase activity (EC 3.2.1.29)). All 
peroxisomal preparations were used within 4 h of the 
animal being killed. 
Peroxisomal fatty acid oxidation was measured as 
in [Z], with the exception that bovine serum albumin 
was absent from the assay. The assay contained 
0.5 mM NAD, 0.2 mM CoA, 0.5 mM dithiothreitol 
and 0.005% (v/v) Triton X-100. Rates of NAD 
reduction were measured by using an Aminco DW-2 
spectrophotometer operated in dual wavelength mode 
(340-400 nm). Assays were carried out at 36’C. 
Peroxisomal oxidation of [ 14-‘4C]erucoyl-CoA 
was also measured as release of HC104 (5%, v/v) 
soluble radioactivity. The incubation mixture con- 
tained 68 mM KCl, 10 mM Hepes, 10 mM Pi, 
0.15 mM COG, 1 mM di~o~reitol, 20 &i 
~14-i4C]erucoyl-CoA (spec. act. 3904 dpm/~ol) and 
defatted bovine serum albumin (30 ~gglnmol acyl- 
CoA) (pH 7.4). Samples taken from these incubations 
were also used for radio-gas-liquid chromatographic 
analysis. Incubations were carried out at 30°C. 
[ 14-‘4C]Erucoyl-CoA was prepared from the 
corresponding succinimide ster essentially as in [9]. 
Unlabelled acyl-CoA ester were synthesized by the 
mixed anhydride procedure [lo]. Purities of acyl- 
CoA preparations were checked by thin layer 
chromatography [ 1 I]. Radio-gas-liquid chro- 
matographic analysis howed that [ 14-r4C]erucoyl- 
CoA contained only one peak of radioactivity. 
The fatty acid products from peroxisomal oxidation 
of [ 14-‘4C]erucoyl-CoA were analysed as methyl 
esters by radio-gas-liquid chromatography on a 
column of 10% SP-2340 on Chromosorb W AW 
(Supelco Inc., PA) as in [6]. 
Solutions of acyl-CoA esters were assayed 
spectrophotometrically [ 121 by using purified 
carnitine pahnitoyltransferase (EC 2.3 .1.2 1) (H.O., 
unpublished), or carnitine acetyltransferase 
(BC 2.3.1.7). Behenoyl-CoA ((&:o) had to be 
assayed as the hydroxamate ster [ 141, because it
was not a good substrate for carnitine palmitoyl- 
transferase. 
Student’s paired t-test was used to determine 
the significance of differences between means. 
Proteins were measured by using the Bio-Rad protein 
assay kit (Bio-Rad Labs, USA). 
3. Results and discussion 
It has been shown that peroxisomal rates of 
oxidation of short chain acyl-CoA esters are very 
low; butyrylCoA is not oxidized at all 121. Maximal 
rates of oxidation were found with lauroyl-CoA and 
palmitoyl-CoA 121. The data presented in fig.1 partly 
confirm these findings. We have, however, found a 
clear peak rate of oxidation with myristoyl-CoA, as 
far as the saturated acyl-CoA esters are concerned. 
With carbon chain lengths >16 atoms a marked 
decrease in oxidation rate is observed. This suggests 
that peroxisomes are not likely to be involved in the 
oxidation of long saturated acids. With mono- 
unsaturated acyl-CoA esters of identical chain lengths 
(p~itoleoyl~oA, oleoyl_CoA, gadeoleoyl-CoA 
and erucoylCoA), however, rates of oxidation were 
higher by a factor of 10 (excepting palmitoleoyl- 
CoA). In this series a clear peak rate of oxidation was 
achieved with oleoyl-CoA. These results therefore 
suggest that peroxisomes, in clofibrate-treated rats, 
may play a significant role in the cellular oxidation 
of long mono-unsaturated fatty acids, in particular 
the (&-monoenes (here represented by erucoyl- 
CoA). 
The peroxisomal rate of erucoyl-CoA oxidation 
may be taken to be equivalent to -10 nmol acetyl- 
~oups~rn~/rng protein (assum~g 1NADH 
generated =1 acetyl-group roduced ]2]). The 
mitochondri~ oxidation of erucoyl~~ni~e has 
been measured to -5- 10 mnol acetyl-groups/min/mg 
protein [6,14,15]. This suggests hat the peroxisomal 
specific activity of erucic acid oxidation is not less 
than that of the mitochondria. 
The difference in oxidation rates between 
saturated and mono-unsaturated fatty acids 
observed with isolated peroxisomes (fig.1) contrasts 
with the mitochondrial rates of P-oxidation of the 
corresponding substrate pairs. With isolated 
mitochond~a only marginal differences in rates of 
oxidation of stearoyl-/oleoylcamitine and aracidoyl./ 
gadeoleoylcamitine have been found f 141. 
Another noteworthy property of peroxisomal 
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Fig.1. Rates of oxidation of saturated and rnono~n~t~t~ 
acylCoA esters of different chain lengths by isolated 
peroxisomes. Rates of acylCoAdependent NAD reduction 
have been plotted against carbon chain length of the various 
acyl-CoA esters. The plotted values represent he mean and 
SD obtained with at least 3 different peroxisomal preparations. 
Each assay contained 10 PM acylCoA and 60-150 pg 
peroxisomal protein, in 2 ml total vol. The details of the 
assay are in section 2. Results obtained with saturated acyl- 
CoA esters are indicated by (0) and those obtained with 
mono-unsaturated species by (a). The mono-unsaturated 
acyl-CoA esters used were: pahnitoleoylCoA ($6: I), 
oleoylCoA (CLS: l), gadeoylCoA (C20: 1) and erucoylCoA 
(C22: l). Results obtained with the trans-isomers elaidoyl- 
CoA (CL& 1) and br~doyl~oA (C22: 1) are indicated by (+). 
&oxidation is that the rate of oxidation of elaidoyl- 
CoA (tran~-C~~,~) is not significantly different from 
that of the corresponding S-isomer (oleoyl-CoA) 
(fiO.85, ~8; see fig.1). This is also different from 
mitochondrial P-oxidation, where it has been found 
that elaidoylcarnitine is oxidized considerably slower 
than oleoylcarnitine f 163. Brassidoyl-CoA (trans- 
Gzzl) is similarly oxidized by peroxisomes at a rate 
which is not si~i~~tly different from that of the 
corresponding c&-isomer (erucoyl_CoA). Mitochondri~ 
oxidation of the corresponding acylc~~t~es i  not 
si~~cantly different, but this may be due to very 
low rates of &oxidation of these acylcarnitines [ 141. 
These findings, however, suggest that peroxisomes in
clofibrate-treated animals may be important in the 
cellular oxidation of trans-fatty acids. 
The recorder tracing presented in fig.2 shows that 
a limiting amount of erucoyl-CoA undergoes about 
three relatively fast cycles of oxidation, as measured 
by NADH generated. Further oxidation is much 
slower, although sustained. This suggests hat 
peroxisomal &oxidation is primarily concerned with 
chain-~orte~ng of erucoyl-CoA, ~~0~~ some 
further oxidation takes place. A similar conclusion 
has been reported as regards peroxisomal oxidation 
of palmitoylCoA, although the number of&oxidation 
cycles has varied from 2 [l] to 5 [2]. ErucoylCoA 
was always found to be oxidized in this way, 
irrespective of the quantity of erucoyl-CoA added 
(data not shown). 
Data from the literature suggest that peroxisomal 
&oxidation is entirely dependent on NAD, although 
nothing appears to have been reported regarding 
340 - 100 “Ill 
nmoles NADH 
Fig.2. Progress-curve for NAD reduction caused by a limiting 
amount of erucoylCoA. A typical tracing showing that 
erucoylCoA undergoes three fast cycles of oxidation 
followed by a steady, but much slower, rate of reaction. The 
tracing shown here resulted from the addition of 5 nmol 
erucoylCoA. As 16.2 nmol NADH have been formed after 
6 mm; this gives 16.2/S -3.2 cycles of p-oxidation. The 
u&belled arrow indicates point of addition of 5 nmol 
erucoyl-CoA. This assay contained 110 pg peroxisomal 
protein. The details of the assay have otherwise been 
described in the legend to 4.1 
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Fig.3. The effect of NAD and NADP on peroxisomal oxida- 
tion of [ 14J4C]erucoylCoA. The oxidation of [ 14-“Clerucoyl- 
CoA was followed by measuring the release of acid-soluble 
radioactivity after various times of incubation in the presence 
of 0.5 mM NAD alone (o), 0.5 mM NADP alone (o), in the 
combined presence of 0.5 mM NAD and 0.5 mM NADP (A) 
and in the absence of added NAD and NADP (0). The 
incubation mixture contained 0.55 mg peroxisomal protein/ 
ml mixture. The details are in section 2. 
NADP [ 1,2]. The data in fig.3 show that, although 
NAD alone gives practically maximal oxidation of 
[ 14-r4C]erucoyl-CoA, there is significant oxidation 
also in the presence of NADP alone. Interestingly, 
the combined presence of NAD and NADP gives a 
slightly higher extent of oxidation than NAD alone. 
This pattern was found with 4 different peroxisomal 
preparations, although the amount of radioactivity 
released has differed by a factor of 2. The latter 
phenomenon may be due to different degrees of 
induction of peroxisomal /I-oxidation. As regards 
NADP, no NADP reduction was observed with the 
spectrophotometric assay for peroxisomsl P-oxidation, 
indeed when NADP was added prior to NAD inhibition 
of NAD reduction was observed (data not shown). 
The finding that mitochondrial preparations can 
be stimulated to shorten [ 14-14C]erucic a id in the 
presence of added NADP [7] may be explained in the 
light of the above results. As mitochondria prepared by 
conventional centrifugation will contain appreciable 
quantities of peroxisomes, this phenomenon islikely 
to be due to peroxisomal oxidation. No additional 
sites for erucic acid oxidation need be postulated, 
In the light of our finding that peroxisomal 
P-oxidation of erucoyl-CoA primarily involves three 
cycles of oxidation we have analysed the fatty acid 
oxidation products, and the results are presented 
in fig.4. It can be seen that that the intermediates 
generated by the first three cycles of oxidation 
constitute -90% of detectable chain-shortened 
products, in agreement with the spectrophotometric 
results (fIg.3). A small amount of C14:1 (product of 
the fourth oxidation cycle) was also found. Samples 
were also examined for shorter oxidation products 
(e.g., acetate, as volatile fatty acids), but no 
detectable amounts were found. 
5 10 15 20 
time I min I 
5 10 15 20 
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Fig.4. Fatty acid products of peroxisomal oxidation of 
[ 1Cr’C]erucoylCoA. Peroxisomes (1.5 mg protein) were 
incubated as in section 2, the total incubation volume being 
3.5 ml. Samples (0.6 ml) were withdrawn at the time intervals 
indicated in the figure, and mixed with 0.3 ml 5 M KOH. 
After 30 min at 85°C they were cooled, acid&d with HCl, 
and extracted twice with 5 ml chloroform/methanol (2:1, 
v/v). After methylation the samples were analysed by radio- 
gas-liquid chromatography as in section 2. Samples (0.2 ml) 
from the same incubation were withdrawn at the same time- 
intervals for measurement of acid-soluble radioactivity. In 
(a)Cl4:1,Cl6:I,ClS:l,C2O:I,C22:1 areindicatedby (a), 
(A), (o), (0) and (o), respectively. The rate of disappearance 
of C22:1 (1.01) after -3 mln incubation, is close to the sum 
of rates of appearance of C 16~1 (0.31), Cl&l (0.34) and 
Czo: 1 (0.38). In (b) acidsoluble radioactivity data have been 
expressed in terms of nmol [ 14-“C]erucoylCoA oxidlsed to 
give acid-soluble radioactivity per mg peroxisomal protein. 
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Because measurable quantities of acid-sohrble 
radioactivity were formed by peroxisomal oxidation 
of [ 14-14C]erucoyl-CoA, a fraction of the substrate 
must be oxidised beyond the five cycles of oxidation 
required to generate acid-soluble radioactivity (-0.3% 
of the added [ 14-14C]erucoyl-CoA, see fig.4). The 
failure to detect his by radio-gas-liquid chromatography 
is probably due to the poorer sensitivity of the 
proportional counter elative to the liquid scintilia- 
tion spectrometer. ft is also noteworthy that the 
intermediates which accumulate are identical to 
those found when erucic acid chain shortening was 
stimulated by NADP [7]. 
The results presented here, in our view, support 
the proposal [171 that peroxisomal &oxidation may 
be of significance as regards the cellular oxidation of 
long chain mono-unsaturated fatty acids, at least as 
far as clofibrate-treated animals are concerned. The 
products of peroxisomal oxidation should be well 
suited for subsequent oxidation by mitochondriai 
@-oxidation. 
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